June 29 Quick Takes: BioNTech pockets $250M; plus three biotechs join NASDAQ IPO queue

Temasek takes stake in BioNTech
BioNTech SE (NASDAQ:BNTX) raised about $250 million from Temasek and other undisclosed investors in a private placement comprising $139 million in stock and $112 million in convertible notes. The biotech is partnered with Pfizer Inc. (NYSE:PFE) to develop BNT162, an mRNA-based COVID-19 vaccine (see “Pfizer, BioNTech on Track to Make Hundreds of Millions of Vaccine Doses”).

IPO proposals from ALX, Berkeley Lights, Pandion
A trio of biotechs proposed NASDAQ IPOs Friday...